NFKB1 and Alzheimer disease: Mechanistic studies have shown that it can control microglia activation by regulating the MAPK and PI3K/Akt signaling pathways, and inhibiting the downstream transcription factors NF-κB and AP-1 to play an anti-inflammatory role, thus exerting an anti-AD effect [176].